Literature DB >> 23237888

2012: the year in dementia.

Sam Gandy1, Steven T DeKosky.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23237888      PMCID: PMC4006941          DOI: 10.1016/S1474-4422(12)70284-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  12 in total

1.  APOE ε4 status and traumatic brain injury on the gridiron or the battlefield.

Authors:  Sam Gandy; Steven T Dekosky
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

2.  Propagation of tau pathology in a model of early Alzheimer's disease.

Authors:  Alix de Calignon; Manuela Polydoro; Marc Suárez-Calvet; Christopher William; David H Adamowicz; Kathy J Kopeikina; Rose Pitstick; Naruhiko Sahara; Karen H Ashe; George A Carlson; Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

3.  A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.

Authors:  Thorlakur Jonsson; Jasvinder K Atwal; Stacy Steinberg; Jon Snaedal; Palmi V Jonsson; Sigurbjorn Bjornsson; Hreinn Stefansson; Patrick Sulem; Daniel Gudbjartsson; Janice Maloney; Kwame Hoyte; Amy Gustafson; Yichin Liu; Yanmei Lu; Tushar Bhangale; Robert R Graham; Johanna Huttenlocher; Gyda Bjornsdottir; Ole A Andreassen; Erik G Jönsson; Aarno Palotie; Timothy W Behrens; Olafur T Magnusson; Augustine Kong; Unnur Thorsteinsdottir; Ryan J Watts; Kari Stefansson
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

4.  Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.

Authors:  Kaj Blennow; Henrik Zetterberg; Juha O Rinne; Stephen Salloway; Jenny Wei; Ronald Black; Michael Grundman; Enchi Liu
Journal:  Arch Neurol       Date:  2012-08

5.  Chronic traumatic encephalopathy in an Iraqi war veteran with posttraumatic stress disorder who committed suicide.

Authors:  Bennet Omalu; Jennifer L Hammers; Julian Bailes; Ronald L Hamilton; M Ilyas Kamboh; Garrett Webster; Robert P Fitzsimmons
Journal:  Neurosurg Focus       Date:  2011-11       Impact factor: 4.047

6.  Safety and biomarker effects of solanezumab in patients with Alzheimer's disease.

Authors:  Martin Farlow; Steven E Arnold; Christopher H van Dyck; Paul S Aisen; B Joy Snider; Anton P Porsteinsson; Stuart Friedrich; Robert A Dean; Celedon Gonzales; Gopalan Sethuraman; Ronald B DeMattos; Richard Mohs; Steven M Paul; Eric R Siemers
Journal:  Alzheimers Dement       Date:  2012-06-05       Impact factor: 21.566

7.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

8.  Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

Authors:  Johannes Vom Berg; Stefan Prokop; Kelly R Miller; Juliane Obst; Roland E Kälin; Ileana Lopategui-Cabezas; Anja Wegner; Florian Mair; Carola G Schipke; Oliver Peters; York Winter; Burkhard Becher; Frank L Heppner
Journal:  Nat Med       Date:  2012-11-25       Impact factor: 53.440

9.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

10.  Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice.

Authors:  Kelvin C Luk; Victoria M Kehm; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M Y Lee
Journal:  J Exp Med       Date:  2012-04-16       Impact factor: 14.307

View more
  3 in total

1.  Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model.

Authors:  John W Steele; Hannah Brautigam; Jennifer A Short; Allison Sowa; Mengxi Shi; Aniruddha Yadav; Christina M Weaver; David Westaway; Paul E Fraser; Peter H St George-Hyslop; Sam Gandy; Patrick R Hof; Dara L Dickstein
Journal:  J Comp Neurol       Date:  2014-07-01       Impact factor: 3.215

2.  Chronic γ-secretase inhibition reduces amyloid plaque-associated instability of pre- and postsynaptic structures.

Authors:  S Liebscher; R M Page; K Käfer; E Winkler; K Quinn; E Goldbach; E F Brigham; D Quincy; G S Basi; D B Schenk; H Steiner; T Bonhoeffer; C Haass; M Meyer-Luehmann; M Hübener
Journal:  Mol Psychiatry       Date:  2013-09-24       Impact factor: 15.992

3.  MicroRNA-195 prevents dendritic degeneration and neuron death in rats following chronic brain hypoperfusion.

Authors:  Xin Chen; Xue-Mei Jiang; Lin-Jing Zhao; Lin-Lin Sun; Mei-Ling Yan; You Tian; Shuai Zhang; Ming-Jing Duan; Hong-Mei Zhao; Wen-Rui Li; Yang-Yang Hao; Li-Bo Wang; Qiao-Jie Xiong; Jing Ai
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.